NCT05625412 2025-06-13
A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1 Completed
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd
Ono Pharmaceutical Co. Ltd
Bristol-Myers Squibb
Fox Chase Cancer Center